Karen Feldtmose

Karen Feldtmose has over 35 years of work experience in the pharmaceutical industry. Karen began their career in 1984 as the Director of Analytical Services at Colorcon®. After thirteen years in that role, they joined Teva Pharmaceuticals in 1998 as the Director of Generic R&D. Karen was later promoted to Senior Director of Generic Portfolio, a role they held until 2014. In 2014, Feldtmose joined Johnson Matthey as the Executive Director of Generic Portfolio Development. Lastly, they currently work at Lannett Company as the Senior Director of Portfolio Development, a position they have held since 2019.

Karen Feldtmose attended Ursinus College from 1980 to 1984, although their degree and field of study during that time are unknown.